[INORG-01]Stability, reduction, and cytotoxicity of platinum(IV) anticancer prodrugs bearing carbamate axial ligands: comparison with their carboxylate analogues
Previous[INORG-03]BODI-Pt, a green-light activatable and carboplatin-based platinum(IV) anticancer prodrug with enhanced activation and cytotoxicity
Next